Pitcairn’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-7,064
Closed -$363K 485
2018
Q3
$363K Sell
7,064
-761
-10% -$38.1K 0.04% 345
2018
Q2
$394K Buy
+7,825
New +$397K 0.04% 307
2018
Q1
Sell
-8,347
Closed -$438K 534
2017
Q4
$438K Sell
8,347
-169
-2% -$8.4K 0.04% 287
2017
Q3
$417K Buy
+8,516
New +$405K 0.05% 293
2017
Q2
Sell
-7,132
Closed -$300K 486
2017
Q1
$300K Sell
7,132
-214
-3% -$8.85K 0.04% 363
2016
Q4
$310K Sell
7,346
-1,085
-13% -$44.3K 0.04% 368
2016
Q3
$370K Buy
+8,431
New +$377K 0.05% 314
2016
Q2
Sell
-6,951
Closed -$306K 465
2016
Q1
$306K Buy
6,951
+49
+0.7% +$2.08K 0.04% 334
2015
Q4
$289K Buy
+6,902
New +$291K 0.03% 349
2015
Q3
Sell
-6,914
Closed -$288K 434
2015
Q2
$288K Sell
6,914
-185
-3% -$7.91K 0.03% 370
2015
Q1
$295K Buy
7,099
+380
+6% +$14.7K 0.03% 379
2014
Q4
$250K Buy
6,719
+46
+0.7% +$1.66K 0.03% 408
2014
Q3
$232K Buy
6,673
+537
+9% +$18.5K 0.03% 420
2014
Q2
$205K Sell
6,136
-1,634
-21% -$54.5K 0.02% 439
2014
Q1
$271K Buy
7,770
+376
+5% +$13.2K 0.03% 384
2013
Q4
$263K Sell
7,394
-3,350
-31% -$112K 0.03% 410
2013
Q3
$348K Buy
10,744
+711
+7% +$23.2K 0.04% 326
2013
Q2
$353K Buy
+10,033
New +$349K 0.05% 314

Other funds holding FMS

Pitcairn's FMS Position: Q4 2018 in Review

Pitcairn sold out of Fresenius Medical Care (FMS) in Q4 2018, closing a stake of 7,064 shares — an estimated $363K sold.

Pitcairn first reported a position in FMS in Q2 2013 and held it in 18 quarters. The position peaked at $438K in Q4 2017. 197 funds tracked by Wall St. Rank hold FMS as of Q4 2018.

  • Pitcairn reported no remaining Fresenius Medical Care position as of Q4 2018 after selling out during the quarter.
  • Pitcairn sold 7,064 Fresenius Medical Care shares in Q4 2018, an estimated $363K.
  • Pitcairn first reported a position in Fresenius Medical Care in Q2 2013 and held it in 18 quarters.
  • Pitcairn's Fresenius Medical Care position peaked at $438K in Q4 2017.
  • 197 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2018.

Based on Pitcairn's 13F filing for Q4 2018, filed 12 Feb 2019.